JOURNAL OF ETHNOPHARMACOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2237558, encodeId=0cbb223e558b9, content=偏重的研究方向：中药药理 经验分享：with editor快一个月了，中间手稿从执行编辑手里到主编手里，又从主编手里到执行编辑手里，换了一个执行编辑，with editor状态日期变了三次，不知道什么时候送审，好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd209445807, createdName=ms1000000239595463, createdTime=Mon Nov 18 11:45:45 CST 2024, time=2024-11-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209577, encodeId=2d7822095e741, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：整体速度可以，较快。with editor 大概19-20天，然后Under review，15天左右两个审稿人审稿意见回来了。毕业答辩耽搁了，20天左右才返回去，又过了10天作用二审意见回来了，这次四个审稿人，都是小问题，很快返回去，4天后accept，当天就收到校稿邮件。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Wed Jun 12 21:03:31 CST 2024, time=2024-06-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2216912, encodeId=315d221691294, content=审稿速度:1.0 偏重的研究方向：提取单体;民族药 经验分享：主编Alvaro Vilioen怎么样？投稿3天后Submissions Sent Back to Author，要求补充民族药物的应用依据，返修回去状态直接With Editor，目前稿件在主编Alvaro Vilioen手中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a409312137, createdName=ms4000000884840494, createdTime=Fri Jul 26 09:34:23 CST 2024, time=2024-07-26, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2241914, encodeId=a5ab224191439, content=偏重的研究方向：中药 经验分享：没有 TLC, HPLC, GC, MS or NMR怎么办啊，投稿因为这个问题返回来了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf428806282, createdName=ms6000000827739117, createdTime=Wed Dec 11 20:56:00 CST 2024, time=2024-12-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2241720, encodeId=08aa2241e202d, content=偏重的研究方向：中药药效物质基础;中药药理;中药复方 经验分享：24年11.3投稿，主编是Alvaro Viljoen，12.8显示Required Reviews Complete，请问这个主编快吗？这个状态一般得多久啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee116144872, createdName=刺五加, createdTime=Tue Dec 10 19:57:05 CST 2024, time=2024-12-10, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1014533, encodeId=b1ea101453320, content=偏重的研究方向：中药复方制剂 经验分享：文章录用了，前后用了快一年时间，目前没收到要交版面费的邮件，不知道要不要交~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/25/f27bbf8ae0bb1a6d1104d88255c3d75e.jpg, createdBy=8bbb5311996, createdName=萱和谷, createdTime=Sat Sep 04 13:29:51 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239444, encodeId=0a792239444c3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：中药复方 经验分享：一审返修后已经11天了还没重新送审大家都几天送审的呀555, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/e6df258ea12946bd8e6ea106580ec0a4-yj4BAGz4fC8E.jpg, createdBy=0b369352963, createdName=今天我accept了吗, createdTime=Wed Nov 27 10:34:44 CST 2024, time=2024-11-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2173434, encodeId=981b21e3434ac, content=偏重的研究方向：靶点;单体 经验分享：with editor2周多了，要不要催？最近这么慢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1e25413810, createdName=ms9000001673281029, createdTime=Thu Dec 07 08:50:50 CST 2023, time=2023-12-07, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2235991, encodeId=120a2235991ed, content=10天了还在主编手里正常吗，到学术编辑还得卡个半个月吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/062436adbbcd4e2e890574558d3f2ea4/da27de86c40c4ffa9df1b63d464f7910.jpg, createdBy=884a5513476, createdName=姚爪爪, createdTime=Sat Nov 09 11:51:21 CST 2024, time=2024-11-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2234530, encodeId=2f0d22345301e, content=大家最新的稿件号是多少呀，我是10113，想看看前面还有多少个, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/062436adbbcd4e2e890574558d3f2ea4/da27de86c40c4ffa9df1b63d464f7910.jpg, createdBy=884a5513476, createdName=姚爪爪, createdTime=Fri Nov 01 11:01:21 CST 2024, time=2024-11-01, status=1, ipAttribution=)]

2024-11-18 ms1000000239595463 来自北京

偏重的研究方向：中药药理
经验分享：with editor快一个月了，中间手稿从执行编辑手里到主编手里，又从主编手里到执行编辑手里，换了一个执行编辑，with editor状态日期变了三次，不知道什么时候送审，好慌啊

40 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237558, encodeId=0cbb223e558b9, content=偏重的研究方向：中药药理 经验分享：with editor快一个月了，中间手稿从执行编辑手里到主编手里，又从主编手里到执行编辑手里，换了一个执行编辑，with editor状态日期变了三次，不知道什么时候送审，好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd209445807, createdName=ms1000000239595463, createdTime=Mon Nov 18 11:45:45 CST 2024, time=2024-11-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209577, encodeId=2d7822095e741, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：整体速度可以，较快。with editor 大概19-20天，然后Under review，15天左右两个审稿人审稿意见回来了。毕业答辩耽搁了，20天左右才返回去，又过了10天作用二审意见回来了，这次四个审稿人，都是小问题，很快返回去，4天后accept，当天就收到校稿邮件。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Wed Jun 12 21:03:31 CST 2024, time=2024-06-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2216912, encodeId=315d221691294, content=审稿速度:1.0 偏重的研究方向：提取单体;民族药 经验分享：主编Alvaro Vilioen怎么样？投稿3天后Submissions Sent Back to Author，要求补充民族药物的应用依据，返修回去状态直接With Editor，目前稿件在主编Alvaro Vilioen手中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a409312137, createdName=ms4000000884840494, createdTime=Fri Jul 26 09:34:23 CST 2024, time=2024-07-26, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2241914, encodeId=a5ab224191439, content=偏重的研究方向：中药 经验分享：没有 TLC, HPLC, GC, MS or NMR怎么办啊，投稿因为这个问题返回来了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf428806282, createdName=ms6000000827739117, createdTime=Wed Dec 11 20:56:00 CST 2024, time=2024-12-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2241720, encodeId=08aa2241e202d, content=偏重的研究方向：中药药效物质基础;中药药理;中药复方 经验分享：24年11.3投稿，主编是Alvaro Viljoen，12.8显示Required Reviews Complete，请问这个主编快吗？这个状态一般得多久啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee116144872, createdName=刺五加, createdTime=Tue Dec 10 19:57:05 CST 2024, time=2024-12-10, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1014533, encodeId=b1ea101453320, content=偏重的研究方向：中药复方制剂 经验分享：文章录用了，前后用了快一年时间，目前没收到要交版面费的邮件，不知道要不要交~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/25/f27bbf8ae0bb1a6d1104d88255c3d75e.jpg, createdBy=8bbb5311996, createdName=萱和谷, createdTime=Sat Sep 04 13:29:51 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239444, encodeId=0a792239444c3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：中药复方 经验分享：一审返修后已经11天了还没重新送审大家都几天送审的呀555, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/e6df258ea12946bd8e6ea106580ec0a4-yj4BAGz4fC8E.jpg, createdBy=0b369352963, createdName=今天我accept了吗, createdTime=Wed Nov 27 10:34:44 CST 2024, time=2024-11-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2173434, encodeId=981b21e3434ac, content=偏重的研究方向：靶点;单体 经验分享：with editor2周多了，要不要催？最近这么慢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1e25413810, createdName=ms9000001673281029, createdTime=Thu Dec 07 08:50:50 CST 2023, time=2023-12-07, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2235991, encodeId=120a2235991ed, content=10天了还在主编手里正常吗，到学术编辑还得卡个半个月吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/062436adbbcd4e2e890574558d3f2ea4/da27de86c40c4ffa9df1b63d464f7910.jpg, createdBy=884a5513476, createdName=姚爪爪, createdTime=Sat Nov 09 11:51:21 CST 2024, time=2024-11-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2234530, encodeId=2f0d22345301e, content=大家最新的稿件号是多少呀，我是10113，想看看前面还有多少个, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/062436adbbcd4e2e890574558d3f2ea4/da27de86c40c4ffa9df1b63d464f7910.jpg, createdBy=884a5513476, createdName=姚爪爪, createdTime=Fri Nov 01 11:01:21 CST 2024, time=2024-11-01, status=1, ipAttribution=)]

2024-06-12 ms8000001972745472 来自河南省

审稿速度:2.0 | 投稿命中率:50.0
经验分享：整体速度可以，较快。with editor 大概19-20天，然后Under review，15天左右两个审稿人审稿意见回来了。毕业答辩耽搁了，20天左右才返回去，又过了10天作用二审意见回来了，这次四个审稿人，都是小问题，很快返回去，4天后accept，当天就收到校稿邮件。

174 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237558, encodeId=0cbb223e558b9, content=偏重的研究方向：中药药理 经验分享：with editor快一个月了，中间手稿从执行编辑手里到主编手里，又从主编手里到执行编辑手里，换了一个执行编辑，with editor状态日期变了三次，不知道什么时候送审，好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd209445807, createdName=ms1000000239595463, createdTime=Mon Nov 18 11:45:45 CST 2024, time=2024-11-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209577, encodeId=2d7822095e741, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：整体速度可以，较快。with editor 大概19-20天，然后Under review，15天左右两个审稿人审稿意见回来了。毕业答辩耽搁了，20天左右才返回去，又过了10天作用二审意见回来了，这次四个审稿人，都是小问题，很快返回去，4天后accept，当天就收到校稿邮件。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Wed Jun 12 21:03:31 CST 2024, time=2024-06-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2216912, encodeId=315d221691294, content=审稿速度:1.0 偏重的研究方向：提取单体;民族药 经验分享：主编Alvaro Vilioen怎么样？投稿3天后Submissions Sent Back to Author，要求补充民族药物的应用依据，返修回去状态直接With Editor，目前稿件在主编Alvaro Vilioen手中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a409312137, createdName=ms4000000884840494, createdTime=Fri Jul 26 09:34:23 CST 2024, time=2024-07-26, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2241914, encodeId=a5ab224191439, content=偏重的研究方向：中药 经验分享：没有 TLC, HPLC, GC, MS or NMR怎么办啊，投稿因为这个问题返回来了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf428806282, createdName=ms6000000827739117, createdTime=Wed Dec 11 20:56:00 CST 2024, time=2024-12-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2241720, encodeId=08aa2241e202d, content=偏重的研究方向：中药药效物质基础;中药药理;中药复方 经验分享：24年11.3投稿，主编是Alvaro Viljoen，12.8显示Required Reviews Complete，请问这个主编快吗？这个状态一般得多久啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee116144872, createdName=刺五加, createdTime=Tue Dec 10 19:57:05 CST 2024, time=2024-12-10, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1014533, encodeId=b1ea101453320, content=偏重的研究方向：中药复方制剂 经验分享：文章录用了，前后用了快一年时间，目前没收到要交版面费的邮件，不知道要不要交~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/25/f27bbf8ae0bb1a6d1104d88255c3d75e.jpg, createdBy=8bbb5311996, createdName=萱和谷, createdTime=Sat Sep 04 13:29:51 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239444, encodeId=0a792239444c3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：中药复方 经验分享：一审返修后已经11天了还没重新送审大家都几天送审的呀555, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/e6df258ea12946bd8e6ea106580ec0a4-yj4BAGz4fC8E.jpg, createdBy=0b369352963, createdName=今天我accept了吗, createdTime=Wed Nov 27 10:34:44 CST 2024, time=2024-11-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2173434, encodeId=981b21e3434ac, content=偏重的研究方向：靶点;单体 经验分享：with editor2周多了，要不要催？最近这么慢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1e25413810, createdName=ms9000001673281029, createdTime=Thu Dec 07 08:50:50 CST 2023, time=2023-12-07, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2235991, encodeId=120a2235991ed, content=10天了还在主编手里正常吗，到学术编辑还得卡个半个月吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/062436adbbcd4e2e890574558d3f2ea4/da27de86c40c4ffa9df1b63d464f7910.jpg, createdBy=884a5513476, createdName=姚爪爪, createdTime=Sat Nov 09 11:51:21 CST 2024, time=2024-11-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2234530, encodeId=2f0d22345301e, content=大家最新的稿件号是多少呀，我是10113，想看看前面还有多少个, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/062436adbbcd4e2e890574558d3f2ea4/da27de86c40c4ffa9df1b63d464f7910.jpg, createdBy=884a5513476, createdName=姚爪爪, createdTime=Fri Nov 01 11:01:21 CST 2024, time=2024-11-01, status=1, ipAttribution=)]

2024-07-26 ms4000000884840494 来自新南威尔士

审稿速度:1.0
偏重的研究方向：提取单体;民族药
经验分享：主编Alvaro Vilioen怎么样？投稿3天后Submissions Sent Back to Author，要求补充民族药物的应用依据，返修回去状态直接With Editor，目前稿件在主编Alvaro Vilioen手中。

224 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237558, encodeId=0cbb223e558b9, content=偏重的研究方向：中药药理 经验分享：with editor快一个月了，中间手稿从执行编辑手里到主编手里，又从主编手里到执行编辑手里，换了一个执行编辑，with editor状态日期变了三次，不知道什么时候送审，好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd209445807, createdName=ms1000000239595463, createdTime=Mon Nov 18 11:45:45 CST 2024, time=2024-11-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209577, encodeId=2d7822095e741, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：整体速度可以，较快。with editor 大概19-20天，然后Under review，15天左右两个审稿人审稿意见回来了。毕业答辩耽搁了，20天左右才返回去，又过了10天作用二审意见回来了，这次四个审稿人，都是小问题，很快返回去，4天后accept，当天就收到校稿邮件。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Wed Jun 12 21:03:31 CST 2024, time=2024-06-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2216912, encodeId=315d221691294, content=审稿速度:1.0 偏重的研究方向：提取单体;民族药 经验分享：主编Alvaro Vilioen怎么样？投稿3天后Submissions Sent Back to Author，要求补充民族药物的应用依据，返修回去状态直接With Editor，目前稿件在主编Alvaro Vilioen手中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a409312137, createdName=ms4000000884840494, createdTime=Fri Jul 26 09:34:23 CST 2024, time=2024-07-26, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2241914, encodeId=a5ab224191439, content=偏重的研究方向：中药 经验分享：没有 TLC, HPLC, GC, MS or NMR怎么办啊，投稿因为这个问题返回来了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf428806282, createdName=ms6000000827739117, createdTime=Wed Dec 11 20:56:00 CST 2024, time=2024-12-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2241720, encodeId=08aa2241e202d, content=偏重的研究方向：中药药效物质基础;中药药理;中药复方 经验分享：24年11.3投稿，主编是Alvaro Viljoen，12.8显示Required Reviews Complete，请问这个主编快吗？这个状态一般得多久啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee116144872, createdName=刺五加, createdTime=Tue Dec 10 19:57:05 CST 2024, time=2024-12-10, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1014533, encodeId=b1ea101453320, content=偏重的研究方向：中药复方制剂 经验分享：文章录用了，前后用了快一年时间，目前没收到要交版面费的邮件，不知道要不要交~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/25/f27bbf8ae0bb1a6d1104d88255c3d75e.jpg, createdBy=8bbb5311996, createdName=萱和谷, createdTime=Sat Sep 04 13:29:51 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239444, encodeId=0a792239444c3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：中药复方 经验分享：一审返修后已经11天了还没重新送审大家都几天送审的呀555, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/e6df258ea12946bd8e6ea106580ec0a4-yj4BAGz4fC8E.jpg, createdBy=0b369352963, createdName=今天我accept了吗, createdTime=Wed Nov 27 10:34:44 CST 2024, time=2024-11-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2173434, encodeId=981b21e3434ac, content=偏重的研究方向：靶点;单体 经验分享：with editor2周多了，要不要催？最近这么慢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1e25413810, createdName=ms9000001673281029, createdTime=Thu Dec 07 08:50:50 CST 2023, time=2023-12-07, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2235991, encodeId=120a2235991ed, content=10天了还在主编手里正常吗，到学术编辑还得卡个半个月吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/062436adbbcd4e2e890574558d3f2ea4/da27de86c40c4ffa9df1b63d464f7910.jpg, createdBy=884a5513476, createdName=姚爪爪, createdTime=Sat Nov 09 11:51:21 CST 2024, time=2024-11-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2234530, encodeId=2f0d22345301e, content=大家最新的稿件号是多少呀，我是10113，想看看前面还有多少个, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/062436adbbcd4e2e890574558d3f2ea4/da27de86c40c4ffa9df1b63d464f7910.jpg, createdBy=884a5513476, createdName=姚爪爪, createdTime=Fri Nov 01 11:01:21 CST 2024, time=2024-11-01, status=1, ipAttribution=)]

2024-12-11 ms6000000827739117 来自江苏省

偏重的研究方向：中药
经验分享：没有 TLC, HPLC, GC, MS or NMR怎么办啊，投稿因为这个问题返回来了

26 0

[GetPortalCommentsPageByObjectIdResponse(id=2237558, encodeId=0cbb223e558b9, content=偏重的研究方向：中药药理 经验分享：with editor快一个月了，中间手稿从执行编辑手里到主编手里，又从主编手里到执行编辑手里，换了一个执行编辑，with editor状态日期变了三次，不知道什么时候送审，好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd209445807, createdName=ms1000000239595463, createdTime=Mon Nov 18 11:45:45 CST 2024, time=2024-11-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209577, encodeId=2d7822095e741, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：整体速度可以，较快。with editor 大概19-20天，然后Under review，15天左右两个审稿人审稿意见回来了。毕业答辩耽搁了，20天左右才返回去，又过了10天作用二审意见回来了，这次四个审稿人，都是小问题，很快返回去，4天后accept，当天就收到校稿邮件。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Wed Jun 12 21:03:31 CST 2024, time=2024-06-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2216912, encodeId=315d221691294, content=审稿速度:1.0 偏重的研究方向：提取单体;民族药 经验分享：主编Alvaro Vilioen怎么样？投稿3天后Submissions Sent Back to Author，要求补充民族药物的应用依据，返修回去状态直接With Editor，目前稿件在主编Alvaro Vilioen手中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a409312137, createdName=ms4000000884840494, createdTime=Fri Jul 26 09:34:23 CST 2024, time=2024-07-26, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2241914, encodeId=a5ab224191439, content=偏重的研究方向：中药 经验分享：没有 TLC, HPLC, GC, MS or NMR怎么办啊，投稿因为这个问题返回来了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf428806282, createdName=ms6000000827739117, createdTime=Wed Dec 11 20:56:00 CST 2024, time=2024-12-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2241720, encodeId=08aa2241e202d, content=偏重的研究方向：中药药效物质基础;中药药理;中药复方 经验分享：24年11.3投稿，主编是Alvaro Viljoen，12.8显示Required Reviews Complete，请问这个主编快吗？这个状态一般得多久啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee116144872, createdName=刺五加, createdTime=Tue Dec 10 19:57:05 CST 2024, time=2024-12-10, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1014533, encodeId=b1ea101453320, content=偏重的研究方向：中药复方制剂 经验分享：文章录用了，前后用了快一年时间，目前没收到要交版面费的邮件，不知道要不要交~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/25/f27bbf8ae0bb1a6d1104d88255c3d75e.jpg, createdBy=8bbb5311996, createdName=萱和谷, createdTime=Sat Sep 04 13:29:51 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239444, encodeId=0a792239444c3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：中药复方 经验分享：一审返修后已经11天了还没重新送审大家都几天送审的呀555, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/e6df258ea12946bd8e6ea106580ec0a4-yj4BAGz4fC8E.jpg, createdBy=0b369352963, createdName=今天我accept了吗, createdTime=Wed Nov 27 10:34:44 CST 2024, time=2024-11-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2173434, encodeId=981b21e3434ac, content=偏重的研究方向：靶点;单体 经验分享：with editor2周多了，要不要催？最近这么慢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1e25413810, createdName=ms9000001673281029, createdTime=Thu Dec 07 08:50:50 CST 2023, time=2023-12-07, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2235991, encodeId=120a2235991ed, content=10天了还在主编手里正常吗，到学术编辑还得卡个半个月吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/062436adbbcd4e2e890574558d3f2ea4/da27de86c40c4ffa9df1b63d464f7910.jpg, createdBy=884a5513476, createdName=姚爪爪, createdTime=Sat Nov 09 11:51:21 CST 2024, time=2024-11-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2234530, encodeId=2f0d22345301e, content=大家最新的稿件号是多少呀，我是10113，想看看前面还有多少个, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/062436adbbcd4e2e890574558d3f2ea4/da27de86c40c4ffa9df1b63d464f7910.jpg, createdBy=884a5513476, createdName=姚爪爪, createdTime=Fri Nov 01 11:01:21 CST 2024, time=2024-11-01, status=1, ipAttribution=)]

2024-12-10 刺五加来自黑龙江省

偏重的研究方向：中药药效物质基础;中药药理;中药复方
经验分享：24年11.3投稿，主编是Alvaro Viljoen，12.8显示Required Reviews Complete，请问这个主编快吗？这个状态一般得多久啊？

26 0

[GetPortalCommentsPageByObjectIdResponse(id=2237558, encodeId=0cbb223e558b9, content=偏重的研究方向：中药药理 经验分享：with editor快一个月了，中间手稿从执行编辑手里到主编手里，又从主编手里到执行编辑手里，换了一个执行编辑，with editor状态日期变了三次，不知道什么时候送审，好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd209445807, createdName=ms1000000239595463, createdTime=Mon Nov 18 11:45:45 CST 2024, time=2024-11-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209577, encodeId=2d7822095e741, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：整体速度可以，较快。with editor 大概19-20天，然后Under review，15天左右两个审稿人审稿意见回来了。毕业答辩耽搁了，20天左右才返回去，又过了10天作用二审意见回来了，这次四个审稿人，都是小问题，很快返回去，4天后accept，当天就收到校稿邮件。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Wed Jun 12 21:03:31 CST 2024, time=2024-06-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2216912, encodeId=315d221691294, content=审稿速度:1.0 偏重的研究方向：提取单体;民族药 经验分享：主编Alvaro Vilioen怎么样？投稿3天后Submissions Sent Back to Author，要求补充民族药物的应用依据，返修回去状态直接With Editor，目前稿件在主编Alvaro Vilioen手中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a409312137, createdName=ms4000000884840494, createdTime=Fri Jul 26 09:34:23 CST 2024, time=2024-07-26, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2241914, encodeId=a5ab224191439, content=偏重的研究方向：中药 经验分享：没有 TLC, HPLC, GC, MS or NMR怎么办啊，投稿因为这个问题返回来了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf428806282, createdName=ms6000000827739117, createdTime=Wed Dec 11 20:56:00 CST 2024, time=2024-12-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2241720, encodeId=08aa2241e202d, content=偏重的研究方向：中药药效物质基础;中药药理;中药复方 经验分享：24年11.3投稿，主编是Alvaro Viljoen，12.8显示Required Reviews Complete，请问这个主编快吗？这个状态一般得多久啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee116144872, createdName=刺五加, createdTime=Tue Dec 10 19:57:05 CST 2024, time=2024-12-10, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1014533, encodeId=b1ea101453320, content=偏重的研究方向：中药复方制剂 经验分享：文章录用了，前后用了快一年时间，目前没收到要交版面费的邮件，不知道要不要交~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/25/f27bbf8ae0bb1a6d1104d88255c3d75e.jpg, createdBy=8bbb5311996, createdName=萱和谷, createdTime=Sat Sep 04 13:29:51 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239444, encodeId=0a792239444c3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：中药复方 经验分享：一审返修后已经11天了还没重新送审大家都几天送审的呀555, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/e6df258ea12946bd8e6ea106580ec0a4-yj4BAGz4fC8E.jpg, createdBy=0b369352963, createdName=今天我accept了吗, createdTime=Wed Nov 27 10:34:44 CST 2024, time=2024-11-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2173434, encodeId=981b21e3434ac, content=偏重的研究方向：靶点;单体 经验分享：with editor2周多了，要不要催？最近这么慢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1e25413810, createdName=ms9000001673281029, createdTime=Thu Dec 07 08:50:50 CST 2023, time=2023-12-07, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2235991, encodeId=120a2235991ed, content=10天了还在主编手里正常吗，到学术编辑还得卡个半个月吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/062436adbbcd4e2e890574558d3f2ea4/da27de86c40c4ffa9df1b63d464f7910.jpg, createdBy=884a5513476, createdName=姚爪爪, createdTime=Sat Nov 09 11:51:21 CST 2024, time=2024-11-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2234530, encodeId=2f0d22345301e, content=大家最新的稿件号是多少呀，我是10113，想看看前面还有多少个, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/062436adbbcd4e2e890574558d3f2ea4/da27de86c40c4ffa9df1b63d464f7910.jpg, createdBy=884a5513476, createdName=姚爪爪, createdTime=Fri Nov 01 11:01:21 CST 2024, time=2024-11-01, status=1, ipAttribution=)]

2021-09-04 萱和谷

偏重的研究方向：中药复方制剂
经验分享：文章录用了，前后用了快一年时间，目前没收到要交版面费的邮件，不知道要不要交~

120 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237558, encodeId=0cbb223e558b9, content=偏重的研究方向：中药药理 经验分享：with editor快一个月了，中间手稿从执行编辑手里到主编手里，又从主编手里到执行编辑手里，换了一个执行编辑，with editor状态日期变了三次，不知道什么时候送审，好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd209445807, createdName=ms1000000239595463, createdTime=Mon Nov 18 11:45:45 CST 2024, time=2024-11-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209577, encodeId=2d7822095e741, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：整体速度可以，较快。with editor 大概19-20天，然后Under review，15天左右两个审稿人审稿意见回来了。毕业答辩耽搁了，20天左右才返回去，又过了10天作用二审意见回来了，这次四个审稿人，都是小问题，很快返回去，4天后accept，当天就收到校稿邮件。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Wed Jun 12 21:03:31 CST 2024, time=2024-06-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2216912, encodeId=315d221691294, content=审稿速度:1.0 偏重的研究方向：提取单体;民族药 经验分享：主编Alvaro Vilioen怎么样？投稿3天后Submissions Sent Back to Author，要求补充民族药物的应用依据，返修回去状态直接With Editor，目前稿件在主编Alvaro Vilioen手中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a409312137, createdName=ms4000000884840494, createdTime=Fri Jul 26 09:34:23 CST 2024, time=2024-07-26, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2241914, encodeId=a5ab224191439, content=偏重的研究方向：中药 经验分享：没有 TLC, HPLC, GC, MS or NMR怎么办啊，投稿因为这个问题返回来了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf428806282, createdName=ms6000000827739117, createdTime=Wed Dec 11 20:56:00 CST 2024, time=2024-12-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2241720, encodeId=08aa2241e202d, content=偏重的研究方向：中药药效物质基础;中药药理;中药复方 经验分享：24年11.3投稿，主编是Alvaro Viljoen，12.8显示Required Reviews Complete，请问这个主编快吗？这个状态一般得多久啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee116144872, createdName=刺五加, createdTime=Tue Dec 10 19:57:05 CST 2024, time=2024-12-10, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1014533, encodeId=b1ea101453320, content=偏重的研究方向：中药复方制剂 经验分享：文章录用了，前后用了快一年时间，目前没收到要交版面费的邮件，不知道要不要交~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/25/f27bbf8ae0bb1a6d1104d88255c3d75e.jpg, createdBy=8bbb5311996, createdName=萱和谷, createdTime=Sat Sep 04 13:29:51 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239444, encodeId=0a792239444c3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：中药复方 经验分享：一审返修后已经11天了还没重新送审大家都几天送审的呀555, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/e6df258ea12946bd8e6ea106580ec0a4-yj4BAGz4fC8E.jpg, createdBy=0b369352963, createdName=今天我accept了吗, createdTime=Wed Nov 27 10:34:44 CST 2024, time=2024-11-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2173434, encodeId=981b21e3434ac, content=偏重的研究方向：靶点;单体 经验分享：with editor2周多了，要不要催？最近这么慢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1e25413810, createdName=ms9000001673281029, createdTime=Thu Dec 07 08:50:50 CST 2023, time=2023-12-07, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2235991, encodeId=120a2235991ed, content=10天了还在主编手里正常吗，到学术编辑还得卡个半个月吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/062436adbbcd4e2e890574558d3f2ea4/da27de86c40c4ffa9df1b63d464f7910.jpg, createdBy=884a5513476, createdName=姚爪爪, createdTime=Sat Nov 09 11:51:21 CST 2024, time=2024-11-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2234530, encodeId=2f0d22345301e, content=大家最新的稿件号是多少呀，我是10113，想看看前面还有多少个, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/062436adbbcd4e2e890574558d3f2ea4/da27de86c40c4ffa9df1b63d464f7910.jpg, createdBy=884a5513476, createdName=姚爪爪, createdTime=Fri Nov 01 11:01:21 CST 2024, time=2024-11-01, status=1, ipAttribution=)]

2024-11-27 今天我accept了吗来自江苏省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：中药复方
经验分享：一审返修后已经11天了还没重新送审大家都几天送审的呀555

82 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237558, encodeId=0cbb223e558b9, content=偏重的研究方向：中药药理 经验分享：with editor快一个月了，中间手稿从执行编辑手里到主编手里，又从主编手里到执行编辑手里，换了一个执行编辑，with editor状态日期变了三次，不知道什么时候送审，好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd209445807, createdName=ms1000000239595463, createdTime=Mon Nov 18 11:45:45 CST 2024, time=2024-11-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209577, encodeId=2d7822095e741, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：整体速度可以，较快。with editor 大概19-20天，然后Under review，15天左右两个审稿人审稿意见回来了。毕业答辩耽搁了，20天左右才返回去，又过了10天作用二审意见回来了，这次四个审稿人，都是小问题，很快返回去，4天后accept，当天就收到校稿邮件。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Wed Jun 12 21:03:31 CST 2024, time=2024-06-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2216912, encodeId=315d221691294, content=审稿速度:1.0 偏重的研究方向：提取单体;民族药 经验分享：主编Alvaro Vilioen怎么样？投稿3天后Submissions Sent Back to Author，要求补充民族药物的应用依据，返修回去状态直接With Editor，目前稿件在主编Alvaro Vilioen手中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a409312137, createdName=ms4000000884840494, createdTime=Fri Jul 26 09:34:23 CST 2024, time=2024-07-26, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2241914, encodeId=a5ab224191439, content=偏重的研究方向：中药 经验分享：没有 TLC, HPLC, GC, MS or NMR怎么办啊，投稿因为这个问题返回来了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf428806282, createdName=ms6000000827739117, createdTime=Wed Dec 11 20:56:00 CST 2024, time=2024-12-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2241720, encodeId=08aa2241e202d, content=偏重的研究方向：中药药效物质基础;中药药理;中药复方 经验分享：24年11.3投稿，主编是Alvaro Viljoen，12.8显示Required Reviews Complete，请问这个主编快吗？这个状态一般得多久啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee116144872, createdName=刺五加, createdTime=Tue Dec 10 19:57:05 CST 2024, time=2024-12-10, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1014533, encodeId=b1ea101453320, content=偏重的研究方向：中药复方制剂 经验分享：文章录用了，前后用了快一年时间，目前没收到要交版面费的邮件，不知道要不要交~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/25/f27bbf8ae0bb1a6d1104d88255c3d75e.jpg, createdBy=8bbb5311996, createdName=萱和谷, createdTime=Sat Sep 04 13:29:51 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239444, encodeId=0a792239444c3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：中药复方 经验分享：一审返修后已经11天了还没重新送审大家都几天送审的呀555, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/e6df258ea12946bd8e6ea106580ec0a4-yj4BAGz4fC8E.jpg, createdBy=0b369352963, createdName=今天我accept了吗, createdTime=Wed Nov 27 10:34:44 CST 2024, time=2024-11-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2173434, encodeId=981b21e3434ac, content=偏重的研究方向：靶点;单体 经验分享：with editor2周多了，要不要催？最近这么慢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1e25413810, createdName=ms9000001673281029, createdTime=Thu Dec 07 08:50:50 CST 2023, time=2023-12-07, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2235991, encodeId=120a2235991ed, content=10天了还在主编手里正常吗，到学术编辑还得卡个半个月吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/062436adbbcd4e2e890574558d3f2ea4/da27de86c40c4ffa9df1b63d464f7910.jpg, createdBy=884a5513476, createdName=姚爪爪, createdTime=Sat Nov 09 11:51:21 CST 2024, time=2024-11-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2234530, encodeId=2f0d22345301e, content=大家最新的稿件号是多少呀，我是10113，想看看前面还有多少个, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/062436adbbcd4e2e890574558d3f2ea4/da27de86c40c4ffa9df1b63d464f7910.jpg, createdBy=884a5513476, createdName=姚爪爪, createdTime=Fri Nov 01 11:01:21 CST 2024, time=2024-11-01, status=1, ipAttribution=)]

2023-12-07 ms9000001673281029 来自云南省

偏重的研究方向：靶点;单体
经验分享：with editor2周多了，要不要催？最近这么慢吗

184 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237558, encodeId=0cbb223e558b9, content=偏重的研究方向：中药药理 经验分享：with editor快一个月了，中间手稿从执行编辑手里到主编手里，又从主编手里到执行编辑手里，换了一个执行编辑，with editor状态日期变了三次，不知道什么时候送审，好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd209445807, createdName=ms1000000239595463, createdTime=Mon Nov 18 11:45:45 CST 2024, time=2024-11-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209577, encodeId=2d7822095e741, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：整体速度可以，较快。with editor 大概19-20天，然后Under review，15天左右两个审稿人审稿意见回来了。毕业答辩耽搁了，20天左右才返回去，又过了10天作用二审意见回来了，这次四个审稿人，都是小问题，很快返回去，4天后accept，当天就收到校稿邮件。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Wed Jun 12 21:03:31 CST 2024, time=2024-06-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2216912, encodeId=315d221691294, content=审稿速度:1.0 偏重的研究方向：提取单体;民族药 经验分享：主编Alvaro Vilioen怎么样？投稿3天后Submissions Sent Back to Author，要求补充民族药物的应用依据，返修回去状态直接With Editor，目前稿件在主编Alvaro Vilioen手中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a409312137, createdName=ms4000000884840494, createdTime=Fri Jul 26 09:34:23 CST 2024, time=2024-07-26, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2241914, encodeId=a5ab224191439, content=偏重的研究方向：中药 经验分享：没有 TLC, HPLC, GC, MS or NMR怎么办啊，投稿因为这个问题返回来了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf428806282, createdName=ms6000000827739117, createdTime=Wed Dec 11 20:56:00 CST 2024, time=2024-12-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2241720, encodeId=08aa2241e202d, content=偏重的研究方向：中药药效物质基础;中药药理;中药复方 经验分享：24年11.3投稿，主编是Alvaro Viljoen，12.8显示Required Reviews Complete，请问这个主编快吗？这个状态一般得多久啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee116144872, createdName=刺五加, createdTime=Tue Dec 10 19:57:05 CST 2024, time=2024-12-10, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1014533, encodeId=b1ea101453320, content=偏重的研究方向：中药复方制剂 经验分享：文章录用了，前后用了快一年时间，目前没收到要交版面费的邮件，不知道要不要交~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/25/f27bbf8ae0bb1a6d1104d88255c3d75e.jpg, createdBy=8bbb5311996, createdName=萱和谷, createdTime=Sat Sep 04 13:29:51 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239444, encodeId=0a792239444c3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：中药复方 经验分享：一审返修后已经11天了还没重新送审大家都几天送审的呀555, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/e6df258ea12946bd8e6ea106580ec0a4-yj4BAGz4fC8E.jpg, createdBy=0b369352963, createdName=今天我accept了吗, createdTime=Wed Nov 27 10:34:44 CST 2024, time=2024-11-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2173434, encodeId=981b21e3434ac, content=偏重的研究方向：靶点;单体 经验分享：with editor2周多了，要不要催？最近这么慢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1e25413810, createdName=ms9000001673281029, createdTime=Thu Dec 07 08:50:50 CST 2023, time=2023-12-07, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2235991, encodeId=120a2235991ed, content=10天了还在主编手里正常吗，到学术编辑还得卡个半个月吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/062436adbbcd4e2e890574558d3f2ea4/da27de86c40c4ffa9df1b63d464f7910.jpg, createdBy=884a5513476, createdName=姚爪爪, createdTime=Sat Nov 09 11:51:21 CST 2024, time=2024-11-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2234530, encodeId=2f0d22345301e, content=大家最新的稿件号是多少呀，我是10113，想看看前面还有多少个, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/062436adbbcd4e2e890574558d3f2ea4/da27de86c40c4ffa9df1b63d464f7910.jpg, createdBy=884a5513476, createdName=姚爪爪, createdTime=Fri Nov 01 11:01:21 CST 2024, time=2024-11-01, status=1, ipAttribution=)]

2024-11-09 姚爪爪来自浙江省

10天了还在主编手里正常吗，到学术编辑还得卡个半个月吧

69 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237558, encodeId=0cbb223e558b9, content=偏重的研究方向：中药药理 经验分享：with editor快一个月了，中间手稿从执行编辑手里到主编手里，又从主编手里到执行编辑手里，换了一个执行编辑，with editor状态日期变了三次，不知道什么时候送审，好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd209445807, createdName=ms1000000239595463, createdTime=Mon Nov 18 11:45:45 CST 2024, time=2024-11-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209577, encodeId=2d7822095e741, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：整体速度可以，较快。with editor 大概19-20天，然后Under review，15天左右两个审稿人审稿意见回来了。毕业答辩耽搁了，20天左右才返回去，又过了10天作用二审意见回来了，这次四个审稿人，都是小问题，很快返回去，4天后accept，当天就收到校稿邮件。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Wed Jun 12 21:03:31 CST 2024, time=2024-06-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2216912, encodeId=315d221691294, content=审稿速度:1.0 偏重的研究方向：提取单体;民族药 经验分享：主编Alvaro Vilioen怎么样？投稿3天后Submissions Sent Back to Author，要求补充民族药物的应用依据，返修回去状态直接With Editor，目前稿件在主编Alvaro Vilioen手中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a409312137, createdName=ms4000000884840494, createdTime=Fri Jul 26 09:34:23 CST 2024, time=2024-07-26, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=2241914, encodeId=a5ab224191439, content=偏重的研究方向：中药 经验分享：没有 TLC, HPLC, GC, MS or NMR怎么办啊，投稿因为这个问题返回来了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf428806282, createdName=ms6000000827739117, createdTime=Wed Dec 11 20:56:00 CST 2024, time=2024-12-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2241720, encodeId=08aa2241e202d, content=偏重的研究方向：中药药效物质基础;中药药理;中药复方 经验分享：24年11.3投稿，主编是Alvaro Viljoen，12.8显示Required Reviews Complete，请问这个主编快吗？这个状态一般得多久啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee116144872, createdName=刺五加, createdTime=Tue Dec 10 19:57:05 CST 2024, time=2024-12-10, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1014533, encodeId=b1ea101453320, content=偏重的研究方向：中药复方制剂 经验分享：文章录用了，前后用了快一年时间，目前没收到要交版面费的邮件，不知道要不要交~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/25/f27bbf8ae0bb1a6d1104d88255c3d75e.jpg, createdBy=8bbb5311996, createdName=萱和谷, createdTime=Sat Sep 04 13:29:51 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239444, encodeId=0a792239444c3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：中药复方 经验分享：一审返修后已经11天了还没重新送审大家都几天送审的呀555, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202411/e6df258ea12946bd8e6ea106580ec0a4-yj4BAGz4fC8E.jpg, createdBy=0b369352963, createdName=今天我accept了吗, createdTime=Wed Nov 27 10:34:44 CST 2024, time=2024-11-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2173434, encodeId=981b21e3434ac, content=偏重的研究方向：靶点;单体 经验分享：with editor2周多了，要不要催？最近这么慢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1e25413810, createdName=ms9000001673281029, createdTime=Thu Dec 07 08:50:50 CST 2023, time=2023-12-07, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2235991, encodeId=120a2235991ed, content=10天了还在主编手里正常吗，到学术编辑还得卡个半个月吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/062436adbbcd4e2e890574558d3f2ea4/da27de86c40c4ffa9df1b63d464f7910.jpg, createdBy=884a5513476, createdName=姚爪爪, createdTime=Sat Nov 09 11:51:21 CST 2024, time=2024-11-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2234530, encodeId=2f0d22345301e, content=大家最新的稿件号是多少呀，我是10113，想看看前面还有多少个, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/062436adbbcd4e2e890574558d3f2ea4/da27de86c40c4ffa9df1b63d464f7910.jpg, createdBy=884a5513476, createdName=姚爪爪, createdTime=Fri Nov 01 11:01:21 CST 2024, time=2024-11-01, status=1, ipAttribution=)]

2024-11-01 姚爪爪

大家最新的稿件号是多少呀，我是10113，想看看前面还有多少个

35 12

展开12条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务